Tuberculosis Treatment Uptake and Outcomes Among HIV-Positive Patients on Antiretroviral Therapy at a Tertiary Health Facility in South-South, Nigeria
Open Access
- 1 January 2026
- journal article
- Published by SAGE Publications in Journal of the International Association of Providers of AIDS Care (JIAPAC)
- Vol. 25
Abstract
Background: There is a significant intersection between Tuberculosis (TB) and HIV, which has contributed greatly to the disease burden, especially in Nigeria. Among approximately 1.9 million people living with HIV (PLHIV), an estimated 46,000 also had TB in 2019 alone. HIV-associated TB incidence has continuously increased nationally. It is important to understand how PLHIV with TB undergo treatment because this is essential for improving outcomes. This study assessed the uptake of TB treatment and evaluated outcomes among PLHIV receiving antiretroviral therapy at a tertiary healthcare facility in South-South Nigeria. Methods: The study was a hospital-based retrospective cohort study, that reviewed the records of 213 PLHIV treated for TB between January 2015 and December 2019. Patient records were examined and data extracted using a structured pro forma. Analysis was done with IBM SPSS version 26 using descriptive statistics (frequencies and Percentages) and inferential statistics (chi-square test) with statistical significance set at p < 0.05. Results: All participants were enrolled in the National Tuberculosis, Leprosy and Buruli Ulcer Control Programme (NTBLCP). Of these, 182 individuals (85.5%) successfully completed the full 24-week course of anti-tuberculosis therapy. Treatment outcomes were classified separately, with 99 (46.5%) patients cured and 74 (34.7%) completing treatment without bacteriological confirmation, 28 (13.1%) discontinued treatment prematurely, and 12 (5.6%) were referred to other healthcare facilities for continued care. Conclusion: TB treatment outcomes among PLHIV were suboptimal, with notable levels of default and transfer-out. Outcomes were significantly associated with socio-demographic factors and treatment duration. Strengthening adherence, support mechanisms and improving access to affordable diagnostic monitoring services may enhance TB treatment outcomes among PLHIV.Keywords
This publication has 20 references indexed in Scilit:
- Tuberculosis treatment outcomes and associated factors in two states in NigeriaTropical Medicine & International Health, 2020
- Trend and determinants of tuberculosis treatment outcome in a tertiary hospital in Southeast NigeriaJournal of Infection and Public Health, 2020
- HIV and tuberculosis co-infection in a highly HIV-infected population of rivers state, NigeriaJournal of Immunoassay and Immunochemistry, 2018
- Profile, Outcomes, and Determinants of Unsuccessful Tuberculosis Treatment Outcomes among HIV-Infected Tuberculosis Patients in a Nigerian StateTuberculosis Research and Treatment, 2014
- Risk factors for default from tuberculosis treatment in HIV-infected individuals in the state of Pernambuco, Brazil: a prospective cohort studyBMC Infectious Diseases, 2011
- Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative studyBMC Public Health, 2010
- An Algorithm for Tuberculosis Screening and Diagnosis in People with HIVNew England Journal of Medicine, 2010
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- How Soon after Infection with HIV Does the Risk of Tuberculosis Start to Increase? A Retrospective Cohort Study in South African Gold MinersThe Journal of Infectious Diseases, 2005
- Priorities for the Treatment of Latent Tuberculosis Infection in the United StatesNew England Journal of Medicine, 2004